CHP investigates severe paediatric case of COVID-19 co-infected with human metapneumovirus
The Centre for Health Protection (CHP) of the Department of Health today (April 23) received a report of a case of severe paediatric COVID-19 and human metapneumovirus (hMPV) infection and reminded the public to observe personal, hand and environmental hygiene at all times. High-risk individuals should receive a COVID-19 vaccination as soon as possible and receive booster doses at appropriate times to minimise the risk of serious complications and death after infection.
The case involves an eight-month-old girl with good past health, who developed a fever and runny nose since April 19 and sought medical attention from a private doctor the next day. She developed cough and shortness of breath on April 21 and sought medical attention from another private doctor. She attended the Accident and Emergency Department of Hong Kong Adventist Hospital – Tsuen Wan on April 22 and was transferred to the Paediatric Intensive Care Unit of Princess Margaret Hospital for treatment on the same day. Her respiratory specimen tested positive for SARS-CoV-2 virus and hMPV upon laboratory testing. The clinical diagnosis was COVID-19 co-infectedwith hMPV complicated with croup. She is still hospitalised and is in critical condition.
A preliminary investigation revealed that the patient had not received COVID-19 vaccine and had no travel history during the incubation period. Two of her household contacts had presented with respiratory symptoms and had recovered.
"There has been a recent increase in the activity of COVID-19 in the local community. In the past few weeks, the load of SARS-CoV-2 virus from sewage surveillance, the laboratory test positivity rate and the consultation rate of COVID-19 cases in general out-patient clinics have continued to rise. As of April 12, the viral load per capita of SARS-CoV-2 virus was around 390 000 copy/litre, which was significantly higher than the week ending March 15 previously, when it was 85 000 copy/litre," said the Controller of the CHP, Dr Edwin Tsui.
"Genetic analysis has shown that the predominant circulating strains in Hong Kong are still JN.1 and its related variants, and the vaccines currently used in Hong Kong can effectively prevent the related variants. Scientific data shows that timely booster doses of the COVID-19 vaccine for high-risk persons help lower the risk of severe illness and death. Members of the public who have not received the initial dose of the COVID-19 vaccine (including infants and children) should get vaccinated as soon as possible. Those at high risk (particularly the elderly and persons with underlying comorbidities) should receive a booster dose as soon as possible for effective prevention against COVID-19," Dr Tsui added.
Persons with hMPV infection can present with symptoms such as fever, cough, difficulty in breathing or shortness of breath etc. hMPV infection may progress to bronchiolitis or pneumonia. hMPV infection can occur all year round and is more common in late spring and summer locally in general.
Apart from vaccination, in order to prevent COVID-19, influenza, hMPV infection, and other respiratory illnesses as well as transmission in the community, the public should maintain strict personal and environmental hygiene at all times and note the following:
For more information on the COVID-19 Vaccination Programme and the latest recommendations on vaccine use, please refer to the CHP's website.